Please login to the form below

Not currently logged in
Email:
Password:

William Humphries joins board of Clearside Biomedical

New CEO of Merz Pharma’s US operations joins the eyecare firm's board

Clearside Biomedical has appointed CEO of Merz Pharma's North American operations, William Humphries, to its board of directors.

Humphries joins the US-based firm, which specialises in developing eyecare products, just two weeks after his appointment at Merz Inc.

Clearside will be keen to make use of Humphries' 25 years' experience in the pharma industry as it looks to develop its microinjection platform to develop therapeutics for sight threatening conditions such as macular oedema and vascular leakage.

Prior to his appointment at Merz, Humphries was president of the GlaxoSmithKline company Stiefel, which specialises in dermatology.

Humphries has also held senior executive roles at Allergan, including VP of its US skincare business.

"Having served under Bill at Stiefel, I know firsthand how talented he is in the global commercialisation of products in today's healthcare environment and his experience is already providing an important impact to Clearside Biomedical," said Daniel White, Clearside's president and CEO.

"Bill brings a complementary vision to our company and a wealth of knowledge to the table that will help guide our company to achieving its goal of providing valuable medical solutions for patients suffering from sight-threatening illness."

4th April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics